129 related articles for article (PubMed ID: 27369102)
1. [Gordon syndrome: The importance of measuring blood pressure in children].
Bruel A; Vargas-Poussou R; Jeunemaitre X; Labbe A; Merlin E; Bessenay L
Arch Pediatr; 2016 Aug; 23(8):827-31. PubMed ID: 27369102
[TBL] [Abstract][Full Text] [Related]
2. A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3.
Tsuji S; Yamashita M; Unishi G; Takewa R; Kimata T; Isobe K; Chiga M; Uchida S; Kaneko K
BMC Nephrol; 2013 Jul; 14():166. PubMed ID: 23902721
[TBL] [Abstract][Full Text] [Related]
3. Pseudohypoaldosteronism Type II: A Young Girl Presented with Hypertension, Hyperkalemia and Metabolic Acidosis.
Sethar GH; Almoghawi A; Khan N; Altourah W; Ashour NM
J Coll Physicians Surg Pak; 2018 Mar; 28(3):S21-S22. PubMed ID: 29482694
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome).
Glover M; Ware JS; Henry A; Wolley M; Walsh R; Wain LV; Xu S; Van't Hoff WG; Tobin MD; Hall IP; Cook S; Gordon RD; Stowasser M; O'Shaughnessy KM
Clin Sci (Lond); 2014 May; 126(10):721-6. PubMed ID: 24266877
[TBL] [Abstract][Full Text] [Related]
5. CUL3 gene analysis enables early intervention for pediatric pseudohypoaldosteronism type II in infancy.
Osawa M; Ogura Y; Isobe K; Uchida S; Nonoyama S; Kawaguchi H
Pediatr Nephrol; 2013 Sep; 28(9):1881-4. PubMed ID: 23689903
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation in Gordon's syndrome: report of two cases carrying novel heterozygous mutations.
Anglani F; Salviati L; Cassina M; Rigato M; Gobbi L; Calò LA
J Nephrol; 2022 Apr; 35(3):859-862. PubMed ID: 34089516
[TBL] [Abstract][Full Text] [Related]
7. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
Boyden LM; Choi M; Choate KA; Nelson-Williams CJ; Farhi A; Toka HR; Tikhonova IR; Bjornson R; Mane SM; Colussi G; Lebel M; Gordon RD; Semmekrot BA; Poujol A; Välimäki MJ; De Ferrari ME; Sanjad SA; Gutkin M; Karet FE; Tucci JR; Stockigt JR; Keppler-Noreuil KM; Porter CC; Anand SK; Whiteford ML; Davis ID; Dewar SB; Bettinelli A; Fadrowski JJ; Belsha CW; Hunley TE; Nelson RD; Trachtman H; Cole TR; Pinsk M; Bockenhauer D; Shenoy M; Vaidyanathan P; Foreman JW; Rasoulpour M; Thameem F; Al-Shahrouri HZ; Radhakrishnan J; Gharavi AG; Goilav B; Lifton RP
Nature; 2012 Jan; 482(7383):98-102. PubMed ID: 22266938
[TBL] [Abstract][Full Text] [Related]
8. Familial cases of pseudohypoaldosteronism type II harboring a novel mutation in the Cullin 3 gene.
Nakano K; Kubota Y; Mori T; Chiga M; Mori T; Sonoda S; Ueda D; Asakura I; Ikegaya T; Kagawa J; Uchida S; Kubota A
Nephrology (Carlton); 2020 Nov; 25(11):818-821. PubMed ID: 32619053
[TBL] [Abstract][Full Text] [Related]
9. Hyperkalemia in young children: blood pressure checked?
Hollander R; Mortier G; van Hoeck K
Eur J Pediatr; 2016 Dec; 175(12):2011-2013. PubMed ID: 27639857
[TBL] [Abstract][Full Text] [Related]
10. Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers.
Yavas Abali Z; Yesil G; Kirkgoz T; Cicek N; Alpay H; Turan S; Bereket A; Guran T
Pediatr Nephrol; 2020 Mar; 35(3):405-407. PubMed ID: 31529157
[No Abstract] [Full Text] [Related]
11. A case of novel mutation of Cullin 3 gene in pseudohypoaldosteronism type II.
Wang L; Nie M; Guo F; Tian Z; Guo X; Zhang S
J Hypertens; 2022 Jun; 40(6):1239-1242. PubMed ID: 35703886
[TBL] [Abstract][Full Text] [Related]
12. [Does Gordon's syndrome always manifest as hypertension? - a case report of one family].
Cichoń-Kawa K; Mizerska-Wasiak M; Cieślik M; Zaniew M; Pańczyk-Tomaszewska M
Pol Merkur Lekarski; 2019 Nov; 47(281):193-196. PubMed ID: 31812975
[TBL] [Abstract][Full Text] [Related]
13. Pseudohypoaldosteronism types I and II: little more than a name in common.
Casas-Alba D; Vila Cots J; Monfort Carretero L; Martorell Sampol L; Zennaro MC; Jeunemaitre X; Camacho Díaz JA
J Pediatr Endocrinol Metab; 2017 May; 30(5):597-601. PubMed ID: 28593901
[TBL] [Abstract][Full Text] [Related]
14. Gordon syndrome caused by a
Park JH; Kim JH; Ahn YH; Kang HG; Ha IS; Cheong HI
J Pediatr Endocrinol Metab; 2022 Feb; 35(2):253-257. PubMed ID: 34480842
[No Abstract] [Full Text] [Related]
15. Pseudohypoaldosteronism Type II or Gordon Syndrome: A Rare Syndrome of Hyperkalemia and Hypertension With Normal Renal Function.
Manas F; Singh S
Cureus; 2024 Jan; 16(1):e52594. PubMed ID: 38374860
[TBL] [Abstract][Full Text] [Related]
16. A case report of Gordon's syndrome in a 20-year-old male with free medical family history.
Kostakis ID; Tsoukalas NG; Aravantinos DC; Gkizis IG; Cholidou KG; Papadopoulos DP
Hellenic J Cardiol; 2013; 54(1):64-8. PubMed ID: 23340132
[TBL] [Abstract][Full Text] [Related]
17. Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension.
Sharma P; Chatrathi HE
Cell Commun Signal; 2023 Oct; 21(1):286. PubMed ID: 37845702
[TBL] [Abstract][Full Text] [Related]
18. A Novel Homozygous KLHL3 Mutation as a Cause of Autosomal Recessive Pseudohypoaldosteronism Type II Diagnosed Late in Life.
Etges A; Hellmig N; Walenda G; Haddad BG; Machtens JP; Morosan T; Rump LC; Scholl UI
Nephron; 2022; 146(4):418-428. PubMed ID: 35093948
[TBL] [Abstract][Full Text] [Related]
19. Cullin 3 and Blood Pressure Regulation: Insights From Familial Hyperkalemic Hypertension.
Maeoka Y; Cornelius RJ; McCormick JA
Hypertension; 2023 May; 80(5):912-923. PubMed ID: 36861484
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
